RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer ProgramShould read : PFS is considered by the FDA to be a "validated" surrogate endpoint that can lead to shorter approval times through an Accelerated Approval ....